Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Marie‐Claire Pinel"'
Autor:
Bénédicte Mittaine‐Marzac, Arsene Zogo, Jean‐Christophe Crusson, Valerie Cheneau, Marie‐Claire Pinel, Marie‐Laure Brandely‐Piat, Fatma Amrani, Laurent Havard, Elisabeth Balladur, Taina Louissaint, Laurence Nivet, Joel Ankri, Philippe Aegerter, Matthieu De Stampa
Publikováno v:
Cancer Medicine, Vol 10, Iss 7, Pp 2242-2249 (2021)
Abstract Background The COVID‐19 outbreak has posed considerable challenges to the health care system worldwide, especially for cancer treatment. We described the activity and the care organisation of the Hospitalisation At Home (HAH) structure dur
Externí odkaz:
https://doaj.org/article/616e57becb764054bd4668d2d39b4820
Autor:
Laurence Nivet, Laurent Havard, Benedicte Mittaine-Marzac, Jean‐Christophe Crusson, Valerie Cheneau, Taina Louissaint, Matthieu De Stampa, Elisabeth Balladur, Fatma Amrani, Marie‐Claire Pinel, Marie‐Laure Brandely‐Piat, Philippe Aegerter, Arsene Zogo, Joël Ankri
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 7, Pp 2242-2249 (2021)
Cancer Medicine, Wiley, 2021, 10 (7), pp.2242-2249. ⟨10.1002/cam4.3682⟩
Cancer Medicine, Vol 10, Iss 7, Pp 2242-2249 (2021)
Cancer Medicine, Wiley, 2021, 10 (7), pp.2242-2249. ⟨10.1002/cam4.3682⟩
Background The COVID‐19 outbreak has posed considerable challenges to the health care system worldwide, especially for cancer treatment. We described the activity and the care organisation of the Hospitalisation At Home (HAH) structure during the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b983a4c23988b75a00286f765b884233
https://pubmed.ncbi.nlm.nih.gov/33665971
https://pubmed.ncbi.nlm.nih.gov/33665971
Autor:
Jean Pierre Delord, Marie Claire Pinel, Nicolas Isambert, Thierry Nguyen, Alain Ravaud, Aurélie Pétain, Pierre Fumoleau, Laurent Nguyen, Jean Marc Tourani
Publikováno v:
British Journal of Clinical Pharmacology. 77:498-508
Aims Vinflunine (VFL) ditartrate, a novel tubulin-targeted inhibitor, is registered for the treatment of patients with advanced or metastatic urothelial transitional cell carcinoma. This phase I study assessed the effect of renal impairment on the ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6be1e5c8f1e962508f2d8a4adde0b22
https://doi.org/10.1111/bcp.12218
https://doi.org/10.1111/bcp.12218
Autor:
Philippe Bougnoux, Maria Błasińska-Morawiec, Ronan Fougeray, Marie-Claire Pinel, Nicole Tubiana-Mathieu
Publikováno v:
The Breast. 22:58-63
Purpose This open label phase II study evaluated the safety and efficacy of vinflunine in patients with breast cancer previously treated with a vinorelbine-based regimen and who progressed during or within 6 months of completing this chemotherapy. Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddfced258bb365bd7b0b4759a0684fab
https://doi.org/10.1016/j.breast.2012.10.007
https://doi.org/10.1016/j.breast.2012.10.007
Autor:
Marie Claire Pinel, S. Favrel, V. Servent, Loic Mourey, Nicolas Isambert, Véronique Girre, T. Nguyen, Alain Ravaud, Jean Marc Tourani
Publikováno v:
Journal of Geriatric Oncology. 3:41-48
Objective Vinflunine (VFL) is a novel microtubule inhibitor indicated in the treatment of advanced or metastatic urothelial transitional cell cancer after failure of a prior platinum-containing regimen at the recommended dose of 320mg/m² q3 weeks. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::598a930f47c56ea85ed74d3b88926e94
https://doi.org/10.1016/j.jgo.2011.11.008
https://doi.org/10.1016/j.jgo.2011.11.008
Autor:
Caroline Tournoux-Facon, Jaafar Bennouna, Jean Marc Tourani, Marie Claire Pinel, Jean Christophe Pouget, Stéphanie Favrel, Hélène Senellart, Etienne Lemarié
Publikováno v:
Journal of Thoracic Oncology. 6:1247-1253
Introduction Vinflunine (Javlor) has shown significant antitumour activity in advanced non-small cell lung cancer (NSCLC). We propose to define the recommended dose of vinflunine in combination with gemcitabine for treatment of advanced NSCLC in chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64a123b1959a94735068a035a3f713ee
https://doi.org/10.1097/jto.0b013e31821b0f3b
https://doi.org/10.1097/jto.0b013e31821b0f3b
Autor:
Marie Claire Pinel, Rodrig Ramlau, X. Sun, Rafael Rosell, Pierre-Jean Souquet, Guillermo Lopez-Vivanco, Jean Christophe Pouget, Christian Puozzo, Maciej Krzakowski
Publikováno v:
Clinical Lung Cancer. 11:105-113
Background A multicenter phase I/II trial of vinflunine administered in combination with cisplatin at 80 mg/m2 was conducted in order to determine the dose-limiting toxicities, the maximum tolerated dose, and the recommended dose of the combination.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32d16d53c7a45300e414d2c89a0bdf16
https://doi.org/10.3816/clc.2010.n.014
https://doi.org/10.3816/clc.2010.n.014
Autor:
D Talbot, Hélène Boussemart, Liliane Ollivier, Marie-Claire Pinel, H. Taylor, Véronique Cadic, G Dabouis, Jacques Margery, A. Riviere, Graham Dark, Pierre Ruffié
Publikováno v:
Journal of Clinical Oncology. 25:4751-4756
Purpose Malignant pleural mesothelioma (MPM) is a disease of increasing incidence for which treatment options are limited. This study reports the clinical efficacy data for vinflunine, a novel microtubule inhibitor, in MPM. Patients and Methods Patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baded45d0ca79d5fcde275777b39fbc0
https://doi.org/10.1200/jco.2007.12.5641
https://doi.org/10.1200/jco.2007.12.5641
Autor:
T.E. Huat, J.-L. Breton, Jaafar Bennouna, C. Colin, Christian H. Ottensmeier, P. Kosmidis, Jean Marc Tourani, Mary O'Brien, J.-Y. Douillard, Marie Claire Pinel
Publikováno v:
British Journal of Cancer
A multicentre, single-arm, phase II trial designed to determine the efficacy of single-agent vinflunine in patients with advanced non-small-cell lung cancer (NSCLC) previously treated with a platinum-based regimen. The objectives were to assess effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::261616ab09df7880cfdbdb9bd2d32bfa
https://doi.org/10.1038/sj.bjc.6603106
https://doi.org/10.1038/sj.bjc.6603106
Publikováno v:
American journal of clinical oncology. 35(4)
Vinflunine (VFL) (Javlor(®)), a novel fluorinated semisynthetic vinca alkaloid has shown significant antitumor activity in advanced non-small cell lung cancer (NSCLC). We propose to define the recommended dose (RD) of VFL in combination with carbopl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ed0d229de33b52b889a0c6e38ff1ddd
https://pubmed.ncbi.nlm.nih.gov/22814308
https://pubmed.ncbi.nlm.nih.gov/22814308